Avita Medical RCEL 深 沪
等待开盘 11-13 09:30:00 美东时间
16.20
-1.100
-6.36%
华盛通- 最 高17.565
- 今 开17.16
- 成交量 49.58万股
- 最 低 16.125
- 昨 收 17.30
- 总市值 5.09亿
- 52周最高 18.43
- 市盈率 静 --
- 换手率 1.58%
- 52周最低 3.22
- 委 比 48.85%
- 总股本 3142.02万
- 历史最高 55.35
- 量 比 0.58
- 振 幅 8.32%
- 历史最低 3.22
- 每 手 1
- 风险率 3.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 什么信号？多家大行下调英伟达目标价，但维持“买入”评级！
今日重点评级关注：摩根大通：维持CytomX Therapeutics"超配"评级，目标价从11美元升至12美元；康托·菲茨杰拉德：维持Exodus Movement"超配"评级，目标价从15美元升至16美元
今天 11:50
美股大行评级 | 巴克莱维百济神州"超配"评级！目标价从415美元上调至446美元
今日重点评级关注：瑞银：维持Liberty Media"中性"评级，目标价从110美元升至1116美元；杰富瑞：维持伊诺维奥制药"买入"评级，目标价从3美元升至8美元
11-09 14:00
AVITA Medical Q3 2026 Earnings Call Transcript
AVITA Medical (NASDAQ:RCEL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.c...
11-06 06:27
Avita Medical shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q4 sales guidance above estimates.
Avita Medical shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q4 sales guidance above estimates.
11-06 06:05
AVITA Medical Raises FY2026 Sales Guidance from $86.000M-$89.000M to $92.000M-$94.000M vs $86.850M Est
AVITA Medical (NASDAQ:RCEL) raises FY2026 sales outlook from $86.000 million-$89.000 million to $92.000 million-$94.000 million vs $86.850 million estimate.
11-06 05:09
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
BTIG Maintains Buy on AVITA Medical, Raises Price Target to $15
BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $11 to $15.
10-12 17:55
AVITA Medical Q2 2026 Earnings Call Transcript
On Thursday, AVITA Medical (NASDAQ:RCEL) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. Access the ...
10-12 17:37
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
